Browse by Tags

Medicaid Cuts Being Felt in All States – Fewer Doctors Take Medicaid than Medicare

This video talks about Michigan, but it’s alive and well in California as well with a very limited number of physicians that see Medicaid (MediCal) patients. We see millions spent on research, but what good is all the research if there are not enough...

Published Tue, Mar 03 2010 12:37 AM by The Medical Quack

Filed under: Medically Related, Insurance, Physicians, Cancer, Medicaid, State Budgets, healthcare reform, medical care

Gastric Cancer Targeted Therapies – Combination of Targets Prove Effective - UCLA

The HER2 gene mutation is best known for the test for breast cancer and now the mutations are proving to show some target relief with treating gastric cancer. The study is finding that a combination targeted treatment with 2 drugs is having success...

Published Wed, Mar 03 2010 6:24 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, health insurance, Cancer, Oncology, Breast Cancer, United HealthCare, Therapy, UCLA Jonsson Cancer Center, reasearch and development, gastric cancer, targets, herception, Tykerb, HER2

UCLA – Histone Modifications Can Be Used to Predict Outcome and Treatment With Pancreas Cancer – Personalized Medicine

This is a beginning groundwork for a commercial test. This could also lead to tests for other types of cancer, such as prostate and kidney cancer. This is similar to the breast cancer study for inherited genes in short. Pancreas cancer...

Published Thu, Feb 02 2010 6:11 PM by The Medical Quack

Filed under: Medically Related, Technology, personalized medicine, DNA, Genomics, healthcare, Cancer, Research and Development, Translational Medicine, UCLA Jonsson Cancer Center, Pancreas Cancer

United HealthCare Sends Oncology Reports to Doctors – Assessing Cancer Treatment Rules

Once again the drive and race for data is on the move, insurers will fall over themselves 10 times over to get a hold of data to analyze. I agree with the comments from the Komen Foundation, an insurance company should not be doing this type of...

Published Tue, Feb 02 2010 12:11 AM by The Medical Quack

Filed under: Medically Related, Insurance, My Commentaries, health insurance, Claims, Cancer, Oncology, Breast Cancer, Roche, United HealthCare, healthcare reform, Susan G. Komen, Avastic

FDA To Review Teva Biosimilar of Amgen's Neupogen – Authority to Approve? Only Our Congress Knows

Last December Teva announced they were going to ask so now it looks like the FDA has given the ok to review. Due to lack of whatever you want to call it these days in Congress, there are no provisions where a generic version of a biotech drug (aka...

Published Tue, Feb 02 2010 9:21 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Generic Drugs, Congress, Merck, Politics, Amgen, Intellectual property, Teva, Drug approvals, drugs discounts, biosimilar

InteractMD – An Oncologist Discussing The Warnings from Big Organizations on Prostate Cancer Treatment

Say hello to Dr. Michael Benjamin, an oncologist from the blogging community from InteractMD.com who practices in southern California. Today we have his take on all the warnings coming out relative to treatments for prostate cancer. ...

Published Tue, Feb 02 2010 2:36 AM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, healthcare, Cardiology, Cancer, Oncology, Blogging, hormones, video blogging, Michael Benjamin, InteractMD, straight talk

Radiation Procedures Gone Sour – Software and Other Related Failures Lead to Death and Lifetime Illnesses

This is quite a tragic story about 2 specific individuals that were over dosed with radiation treatment. Now there are emerging stories in California about over exposure during brains cancer scans, over 200 patients, but their times of exposure...

Published Mon, Jan 01 2010 11:38 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Education, Cancer, Heatlh IT, software, Heatlhcare, Safety, Algorithms, New York, Treatment plans, Varian System, accountability, radation treatment

Quest Diagnostics Offers New DNA Test to Aid in Detection of Colorectal Cancer

Quest is the first lab to offer the laboratory test based on the Septin9 marker. The test is called the “ColoVantage” test and is not considered a screening test but patients may consider the test as it is less evasive than some of the current tests...

Published Thu, Jan 01 2010 9:24 AM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, Labs, healthcare, Cancer, obesity, Quest Diagnostics, ColoVantage, Biggest Loser

Johnson and Johnson Pulls GeneSearch Breast Cancer Diagnosis Test – Trials Ended

The molecular lab test was approved by the FDA in 2007 to detect breast cancer spreading to the lymph nodes. The test could be beneficial at the time of surgery to determine if additional lymph nodes should be removed instead of having a second...

Published Mon, Jan 01 2010 7:32 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, Breast Cancer, Johnson and Johnson, tests, Genesearch

FDA Approved Bio Identical HRT Versus Premarin and Cancer – Where’s the Numbers FDA and Pharma?

I have been writing about this for a while now, but I wonder why can’t we get some numbers crunched here? We keep hearing about the Bio Identical hormone treatments that are customized, but why can’t we get some numbers that compare “FDA Approved...

Published Fri, Jan 01 2010 4:15 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Diet, NIH, Harvard, HRT, Oprah, estrogen, wellness, hormone replacement therapytherapy, Woman's Heatlh, bio identical hormones, Premarin, Dr. Erika, Erika Schwartz, Women's Health Initiative

German Merck Outlook is to Acquire – Pharma and Chemical Sectors

The article states that Merck , one of the heavy cash companies around today is looking at expanding their horizons with acquisitions that fit the mold, perhaps smaller companies and not the larger biotechs. Just recently I read where Merck in the...

Published Mon, Dec 12 2009 6:28 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Cancer, Merck, Research and Development, chemicals, Erbitux, acquisitions

FDA Releases Video Warning About Non Approved and Fraudulent Products/Ads (video)

The video makes reference not only to websites but also devices to be aware of. Below are a few recent links that have been posted here. Pair indicted on fraud charges in medical-device probe California Doctor Arrested on Fraud Charges...

Published Mon, Dec 12 2009 6:04 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Video, healthcare, Medical Devices, Cancer, FDA, Internet, Fraud, websites, H1N1, CURES

Pfizer Talking about Premarin – Women Need Some Numbers Comparing FDA Approved Bio Identical Drugs with Premarin

If you have kept up with the news of late, you may have read quite a bit about this issue and where the disputes lie. It all goes back to the women's health initiative and the fact that ghostwriting was used to promote the drug. Under...

Published Thu, Dec 12 2009 1:26 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Wyeth, Pfizer, Lawsuits, HRT, Insurance companies, Premarin, Women's Health Initiative, ghostwriters, Dr. Erika Schwartz, Bioidentical HRT, menopause

Killer Cancer Code Cracked in the UK – Lung and Skin Cancer

Now that the code has been “cracked” this will lead to the creation of drugs that will be able to target these areas, and maybe even a cure. This is truly big news as the 2 of the most deadly types of cancer have been identified for targeting. ...

Published Thu, Dec 12 2009 11:31 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Genomics, UK, Cancer, R and D, melanoma, Treatment, Lung Cancer, skin cancer charity

Stand up To Cancer Funds High-Risk/High Reward Cancer Research by 13 Young Scientists – 9.68 Million More In Grants

Since May 2008, SU2C has raised more than $100 million from a wide range of philanthropic, corporate, and organizational donors, as well as the general public. Watch the video below for additional details on how the grants were unlike most in the...

Published Mon, Dec 12 2009 9:30 AM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Cancer, Science, Grants, R and D, Stand up to Cancer, Philanthropy, AACR

Syndication

Recent Posts

Tags

Archives